Susan Eylward serves as General Counsel and Corp Sec at Imunon, Inc., where they oversee executive responsibilities. Since joining the company, Susan Eylward has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 8,251 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | IMNN | $0 | Award | 8,251 | $N/A | Discretionary |
Susan Eylward currently holds 8,251 shares of Imunon, Inc. (IMNN), valued at approximately $0. This represents their equity stake as General Counsel and Corp Sec.
Based on SEC Form 4 filings, Susan Eylward has been a net neutral trader of IMNN stock. They have purchased $0 and sold $0 worth of shares.
Susan Eylward's most recent insider trade was on Jan 2, 2026, when they sold 8,251 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted